These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25661444)

  • 1. Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia.
    Mondet J; Park JH; Menard A; Marzac C; Carillo S; Pourcelot E; Girodon F; Cabagnols X; Lodé L; Socoro N; Chauvet M; Bulabois CE; Cony-Makhoul P; Corm S; Cahn JY; Mossuz P
    Haematologica; 2015 May; 100(5):e176-8. PubMed ID: 25661444
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct molecular abnormalities underlie unique clinical features of essential thrombocythemia in children.
    Fu R; Liu D; Cao Z; Zhu S; Li H; Su H; Zhang L; Xue F; Liu X; Zhang X; Cheng T; Yang R; Zhang L
    Leukemia; 2016 Mar; 30(3):746-9. PubMed ID: 26118316
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.
    Tefferi A; Wassie EA; Guglielmelli P; Gangat N; Belachew AA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Pacilli A; Vannucchi AM; Passamonti F
    Am J Hematol; 2014 Aug; 89(8):E121-4. PubMed ID: 24753125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients.
    Bonifacio M; Montemezzi R; Parisi A; De Matteis G; Bertorelle R; Scaffidi L; Candiotto C; Lippi G; Zamò A; Chilosi M; Pizzolo G; Scarpa A; Krampera M
    Ann Hematol; 2019 Oct; 98(10):2339-2346. PubMed ID: 31250082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.
    Pietra D; Rumi E; Ferretti VV; Di Buduo CA; Milanesi C; Cavalloni C; Sant'Antonio E; Abbonante V; Moccia F; Casetti IC; Bellini M; Renna MC; Roncoroni E; Fugazza E; Astori C; Boveri E; Rosti V; Barosi G; Balduini A; Cazzola M
    Leukemia; 2016 Feb; 30(2):431-8. PubMed ID: 26449662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anagrelide and the CALR mutation allele burden in essential thrombocythemia.
    Atkinson E; Bakri M; Hayat A; Langabeer SE
    Exp Oncol; 2018 Jun; 40(2):152-153. PubMed ID: 29949532
    [No Abstract]   [Full Text] [Related]  

  • 7. Capricious CALR mutated clones in myeloproliferative neoplasms.
    Haslam K; Conneally E; Langabeer SE
    Blood Cells Mol Dis; 2016 Mar; 57():110-1. PubMed ID: 26777583
    [No Abstract]   [Full Text] [Related]  

  • 8. The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients.
    Lau WW; Hannah R; Green AR; Göttgens B
    Blood; 2015 Mar; 125(10):1679-81. PubMed ID: 25745188
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential Thrombocythemia.
    Tefferi A; Pardanani A
    N Engl J Med; 2019 Nov; 381(22):2135-2144. PubMed ID: 31774958
    [No Abstract]   [Full Text] [Related]  

  • 10. CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes.
    Olschok K; Han L; de Toledo MAS; Böhnke J; Graßhoff M; Costa IG; Theocharides A; Maurer A; Schüler HM; Buhl EM; Pannen K; Baumeister J; Kalmer M; Gupta S; Boor P; Gezer D; Brümmendorf TH; Zenke M; Chatain N; Koschmieder S
    Stem Cell Reports; 2021 Nov; 16(11):2768-2783. PubMed ID: 34678208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Shapes Of Megakaryocytes In Essential Thrombocythemia.
    Faraz M; Mansoori H; Ali M; Ali SA
    J Ayub Med Coll Abbottabad; 2022; 34(2):389-391. PubMed ID: 35576311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
    Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H; Bock O
    Ann Hematol; 2007 Apr; 86(4):245-53. PubMed ID: 17262192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment.
    Fu R; Xuan M; Zhou Y; Sun T; Bai J; Cao Z; Zhang L; Li H; Zhang D; Zhang X; Lv C; Xue F; Liu X; Yang R; Zhang L
    Leukemia; 2014 Sep; 28(9):1912-4. PubMed ID: 24732593
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombocytosis.
    Schafer AI
    JAMA; 2015 Sep; 314(11):1171-2. PubMed ID: 26372588
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel CALR somatic mutations in essential thrombocythaemia.
    Riera L; Osella-Abate S; Benevolo G; Beggiato E; Ferrero S; Pich A; Francia di Celle P
    Br J Haematol; 2016 Jun; 173(5):797-801. PubMed ID: 26343915
    [No Abstract]   [Full Text] [Related]  

  • 17. Postpartum haemorrhage in a woman with essential thrombocythemia carrying calreticulin mutation: a case report.
    Villani M; Colaizzo D; Tiscia GL; Chinni E; Bodenizza C; Cascavilla N; Grandone E
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):727-8. PubMed ID: 26650457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CALR versus JAK2 mutated essential thrombocythaemia - a report on 141 patients.
    Trifa AP; Popp RA; Cucuianu A; Bănescu C; Tevet M; Martin B; Murat M; Vesa SC; Dima D; Cândea M; Militaru MS; Pop IV
    Br J Haematol; 2015 Jan; 168(1):151-3. PubMed ID: 25103987
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatic mutations of calreticulin in myeloproliferative neoplasms.
    Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
    N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence.
    Giona F; Teofili L; Capodimonti S; Laurino M; Martini M; Marzella D; Palumbo G; Diverio D; Foà R; Larocca LM
    Blood; 2014 Jun; 123(23):3677-9. PubMed ID: 24904106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.